Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.75 - $0.95 $34,559 - $43,775
-46,079 Reduced 7.3%
584,886 $438,000
Q4 2023

Feb 14, 2024

BUY
$0.7 - $1.33 $287,206 - $545,692
410,295 Added 185.93%
630,965 $599,000
Q2 2023

Aug 14, 2023

SELL
$1.42 - $2.23 $925,793 - $1.45 Million
-651,967 Reduced 74.71%
220,670 $419,000
Q1 2023

May 15, 2023

BUY
$1.28 - $1.73 $820 - $1,108
641 Added 0.07%
872,637 $1.48 Million
Q4 2022

Feb 14, 2023

BUY
$1.16 - $1.8 $354,451 - $550,011
305,562 Added 53.94%
871,996 $1.33 Million
Q3 2022

Nov 14, 2022

BUY
$1.77 - $2.76 $1 Million - $1.56 Million
566,434 New
566,434 $1 Million
Q2 2022

Aug 15, 2022

SELL
$1.15 - $3.25 $25,433 - $71,877
-22,116 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$1.22 - $1.77 $26,981 - $39,145
22,116 New
22,116 $35,000
Q4 2021

Feb 14, 2022

SELL
$1.39 - $5.58 $1.01 Million - $4.06 Million
-726,925 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$4.71 - $5.92 $240,761 - $302,612
-51,117 Reduced 6.57%
726,925 $3.56 Million
Q2 2021

Aug 16, 2021

SELL
$5.32 - $6.53 $1.27 Million - $1.56 Million
-238,897 Reduced 23.49%
778,042 $4.26 Million
Q1 2021

May 17, 2021

BUY
$2.75 - $6.57 $560,741 - $1.34 Million
203,906 Added 25.08%
1,016,939 $5.42 Million
Q4 2020

Feb 16, 2021

SELL
$1.38 - $3.01 $79,074 - $172,473
-57,300 Reduced 6.58%
813,033 $2.13 Million
Q3 2020

Nov 16, 2020

BUY
$1.58 - $4.77 $830,745 - $2.51 Million
525,788 Added 152.6%
870,333 $1.51 Million
Q2 2020

Aug 14, 2020

SELL
$3.74 - $6.28 $1.26 Million - $2.11 Million
-335,781 Reduced 49.36%
344,545 $1.51 Million
Q1 2020

May 14, 2020

BUY
$2.33 - $12.98 $906,575 - $5.05 Million
389,088 Added 133.6%
680,326 $2.67 Million
Q4 2019

Feb 14, 2020

BUY
$6.75 - $11.15 $1.97 Million - $3.25 Million
291,238 New
291,238 $3.12 Million
Q3 2019

Nov 14, 2019

SELL
$8.57 - $10.72 $436,093 - $545,497
-50,886 Closed
0 $0
Q2 2019

Aug 15, 2019

SELL
$7.58 - $10.0 $980,601 - $1.29 Million
-129,367 Reduced 71.77%
50,886 $418,000
Q2 2019

Aug 14, 2019

BUY
$7.58 - $10.0 $1.37 Million - $1.8 Million
180,253 New
180,253 $2.38 Million
Q3 2018

Nov 14, 2018

SELL
$16.81 - $24.58 $2.25 Million - $3.29 Million
-133,848 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$18.6 - $24.94 $11,011 - $14,764
592 Added 0.44%
133,848 $2.58 Million
Q1 2018

May 15, 2018

BUY
$20.86 - $26.6 $2.48 Million - $3.17 Million
119,119 Added 842.6%
133,256 $3.07 Million
Q4 2017

Feb 14, 2018

SELL
$20.9 - $49.36 $4.95 Million - $11.7 Million
-236,661 Reduced 94.36%
14,137 $348,000
Q3 2017

Nov 14, 2017

BUY
$39.62 - $46.17 $9.94 Million - $11.6 Million
250,798
250,798 $10.6 Million

Others Institutions Holding DBVT

About DBV Technologies S.A.


  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $745M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.